Clinical trials
Carcinoma, Non-Small-Cell Lung trials in Serbia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Active, not recruiting | 8 |
| Terminated | 8 |
| Recruiting | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 6 |
| AstraZeneca | 4 |
| AbbVie | 3 |
| Boehringer Ingelheim | 3 |
| Helsinn Therapeutics (U.S.), Inc | 2 |
| Mirati Therapeutics Inc. | 2 |
| NovoCure GmbH | 2 |
| Samsung Bioepis Co., Ltd. | 2 |
| Summit Therapeutics | 2 |
| Synta Pharmaceuticals Corp. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 48 |
| Lung Neoplasms | 9 |
| Neoplasms | 7 |
| Neoplasm Metastasis | 5 |
| Cachexia | 3 |
| Adenocarcinoma of Lung | 1 |
| Anemia | 1 |
| Appendiceal Neoplasms | 1 |
| Brain Neoplasms | 1 |
| Bronchial Neoplasms | 1 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.